Ledger.Open graph →
SEC Form D · filed June 28, 2017

PLx Pharma Inc

Offering
$18.2M
Sold
$18.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
HOUSTON, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Gary J. Mossman · Houston, TXExecGary J. Balkema · Houston, TXDirectorDavid J. Jorden · Houston, TXExecKirk J. Calhoun · Houston, TXDirectorNatasha J. Giordano · Houston, TXExec · DirectorMichael J. Valentino · Houston, TXExec · DirectorDavid J. Luci · Houston, TXDirectorJennifer S. Strickland · Austin, TXDirectorFrederic L. Puzin · PARIS, I0Exec · DirectorDavie Fedel · Henderson, NVExecDaniel P. Howell · Chicago, ILExecMichael Martin · New York, NYDirectorRobert J. Casale · Houston, TXDirectorJohn J. Hadden · Houston, TXDirectorWayne Jones · Henderson, NVDirectorGeorge W. Pasha, Iv · San Rafael, CADirectorMarc E. Sacks · Chicago, ILExecMark Deutschmann · Nashville, TNExec · DirectorKevin Clark · Springdale, ARExec · DirectorJacob Huff · Louisville, KYExec · DirectorDavid J. Luci · Houston, TXDirectorRobert J. Casale · Houston, TXDirectorJohn J. Hadden · Houston, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗